GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a substantial innovation in how we handle type 2 diabetes . These new therapies work by stimulating the body’s natural GLP-1 process, https://ok-social.com/story7287808/glp-1-a-significant-approach-in-diabetes-care